retatrutide clinical trial results safety Biggest obesity news ๐จ TRIUMPH-1 are here: Retatrutide's phase 3 showed up to 28% average weight loss over 80 weeks โ with nearly half of patients losing over 30% of Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Nov 23 - Nov 28



























